| # | Drug | Count |
|---|---|---|
| 0 | DABIGATRAN ETEXILATE MESYLATE | 17 |
| 1 | RIVAROXABAN | 17 |
| 2 | DABIGATRAN ETEXILATE | 16 |
| 3 | ASPIRIN | 9 |
| 4 | ASPIRIN 325 MG | 9 |
| 5 | ASPIRIN 81 MG | 9 |
| 6 | FUROSEMIDE | 9 |
| 7 | CLOPIDOGREL | 7 |
| 8 | ALLOPURINOL | 6 |
| 9 | DIGOXIN | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HEXYLRESORCINOL | 1 | 0.0455 |
| 1 | MIGLITOL | 1 | 0.0010 |
| 2 | SODIUM CITRATE | 1 | 0.0008 |
| 3 | NIZATIDINE | 1 | 0.0007 |
| 4 | NORELGESTROMIN AND ETHINYL ESTRADIOL | 1 | 0.0005 |
| 5 | IBANDRONATE SODIUM | 1 | 0.0003 |
| 6 | EDOXABAN TOSYLATE | 2 | 0.0003 |
| 7 | VONOPRAZAN FUMARATE | 2 | 0.0002 |
| 8 | DABIGATRAN ETEXILATE MESYLATE | 17 | 0.0002 |
| 9 | FLUVASTATIN SODIUM | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 2 | 0.0002 |
| 1 | alpha-Glucosidase Inhibitor [EPC] | 1 | 0.0002 |
| 2 | Antifibrinolytic Agent [EPC] | 1 | 0.0001 |
| 3 | Cardiac Glycoside [EPC] | 6 | 0.0001 |
| 4 | Factor Xa Inhibitor [EPC] | 20 | 0.0001 |
| 5 | Thiazide-like Diuretic [EPC] | 3 | 0.0001 |
| 6 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 2 | 0.0001 |
| 7 | Cholinesterase Inhibitor [EPC] | 1 | 0.0001 |
| 8 | Programmed Death Ligand-1 Blocker [EPC] | 1 | 0.0000 |
| 9 | Epidermal Growth Factor Receptor Antagonist [EPC] | 2 | 0.0000 |